Abstract 104P
Background
Gastrointestinal stromal tumor (GIST) is a rare type of soft tissue sarcoma that most commonly arises from gastric mesenchymal cells. This study represents the first-ever form of GIST registry or database in Lebanon. The aim of this study is to describe and compare the Lebanese cohort of GIST cases and their management to the findings of international reports and gold standards.
Methods
This is a retrospective medical chart review of GIST cases diagnosed at the American University of Beirut Medical Center and Hammoud Hospital University Medical Center between the years 1996 and 2017.
Results
The database includes 106 GIST cases with a median age of 63.5 years (24-90). The median tumor size is 6 cm (0.3-21) with the most common presenting symptoms being abdominal pain and anemia. Endoscopy is the most commonly utilized diagnostic modality (49%) with confirmatory biopsy done in 42% of the cases. The most common tumor location is gastric (56.7%) followed by the small intestine (32.7%) and colon (7.7%). Noteworthy, the most common tumor size in females is between 5-10cm while in males is between 2-5cm. The most common cell type identified is the spindle cell (65.7%). CD 117 and CD 34 are positive in 91% and 78% of the cases, respectively. Only 14.7% of the cases received neoadjuvant therapy in the form of chemo- or targeted therapy while 31% received adjuvant therapy in either form. For cases that received adjuvant imatinib or sunitinib, the median tumor size is 8.8cm (4-20cm). Most patients (91%) underwent surgery, either by laparotomy (66%) or laparoscopy (34%). Of those, 97.7% had negative surgical margins. Recurrence occurred in 18.7% of cases with regional and distant recurrence occurring equally (35%) versus local recurrence (30%). The 3- and 5-year disease-free survival is 80% and 76% respectively.
Conclusions
Findings from this collaborative study add to the international epidemiology of GIST. It also shows that GIST features, as well as medical and surgical practices in this Lebanese cohort, conform with those reported from other populations.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
119P - Clinicopathological features and roles of lymph node metastases in gastric cancer: A single-center retrospective study in China
Presenter: yuming zhang
Session: Poster viewing 02
120P - Clinical implication of DNA damage response gene in advanced gastric cancer stage IV and recurrent gastric cancer patients after gastrectomy treated palliative chemotherapy
Presenter: In Gyu Hwang
Session: Poster viewing 02
121P - Treatment patterns and outcomes of recurrent/metastatic esophageal cancer: Real-world data
Presenter: Amrith B P
Session: Poster viewing 02
122P - Efficacy and safety of mFOLFOX-6 in advanced gastric cancer: A prospective observational study
Presenter: Amrith B P
Session: Poster viewing 02
123P - Sarcomatoid carcinoma of gall bladder: A series of 14 cases from a single tertiary-care oncology centre
Presenter: Subhash Yadav
Session: Poster viewing 02
124P - Clinical profile and treatment outcomes of hepatocellular carcinoma from a tertiary care hospital in South India: A retrospective study
Presenter: Gayathri Nair
Session: Poster viewing 02
125P - A parametric network meta-analysis of PD-1 inhibitors in second-line treatment for advanced esophageal squamous cell carcinoma
Presenter: Shubhram Pandey
Session: Poster viewing 02
126P - Late line FOLFOX therapy after prior cisplatin-based regimen in advanced esophageal squamous cell carcinoma: A multi-institutional retrospective study
Presenter: Keitaro Shimozaki
Session: Poster viewing 02
127P - LABS score: The prognostic tool for advanced hepatocellular carcinoma treated with FOLFOX4 and real-world efficacy from a single-center retrospective study
Presenter: Jirapat Wonglhow
Session: Poster viewing 02
128P - Survival outcome of gastric cancer patients in a tertiary care center: A 10-year single center retrospective study
Presenter: Dawn Lynn Guardiario
Session: Poster viewing 02